| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 145.28B | 148.60B | 144.57B | 140.19B | 140.86B | 136.85B |
| Gross Profit | 19.86B | 20.33B | 19.30B | 17.66B | 17.11B | 16.47B |
| EBITDA | 21.27B | 23.68B | 21.03B | 20.67B | 19.18B | 17.92B |
| Net Income | 10.10B | 12.69B | 9.80B | 9.74B | 8.93B | 8.58B |
Balance Sheet | ||||||
| Total Assets | 191.08B | 204.59B | 192.09B | 191.36B | 177.44B | 170.92B |
| Cash, Cash Equivalents and Short-Term Investments | 37.06B | 41.15B | 41.41B | 41.20B | 37.24B | 26.55B |
| Total Debt | 28.08B | 26.00B | 28.97B | 31.11B | 33.50B | 34.28B |
| Total Liabilities | 58.22B | 60.20B | 59.93B | 63.41B | 61.35B | 62.40B |
| Stockholders Equity | 130.79B | 142.04B | 130.05B | 125.93B | 114.17B | 106.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.78B | 8.36B | 10.43B | 10.48B | 1.89B |
| Operating Cash Flow | 0.00 | 17.17B | 16.27B | 14.51B | 16.50B | 12.24B |
| Investing Cash Flow | 0.00 | -5.40B | -10.42B | -4.07B | -6.09B | -11.01B |
| Financing Cash Flow | 0.00 | -9.51B | -9.12B | -6.66B | -3.60B | 2.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥169.00B | 8.87 | ― | 1.84% | 18.74% | 223.25% | |
71 Outperform | ¥152.55B | 11.32 | ― | 2.22% | 2.79% | 32.76% | |
70 Outperform | ¥141.45B | 9.94 | ― | 3.65% | 3.06% | 1.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥936.36B | 14.94 | 9.97% | 3.54% | 11.19% | 5.65% | |
59 Neutral | ¥320.51B | 16.37 | 8.30% | 2.50% | 5.27% | -5.79% | |
56 Neutral | ¥1.26T | 208.09 | ― | 2.99% | -0.90% | -81.16% |